SORRENTO THERAPEUTICS INC (SRNE) Forecast, Price Target & Analyst Ratings

NASDAQ:SRNE • US83587F2020

Current stock price

0.3073 USD
-0.08 (-20.26%)
At close:
0.2801 USD
-0.03 (-8.85%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SORRENTO THERAPEUTICS INC (SRNE).

Forecast Snapshot

Consensus Price Target

Price Target
$7.82
+ 2,444.76% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
Period
Q4 / 2022
EPS Estimate
-$0.23
Revenue Estimate
16.905M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.22%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$7.82
Upside
+ 2,444.76%
From current price of $0.31 to mean target of $7.82, Based on 9 analyst forecasts
Low
$5.05
Median
$5.10
High
$13.65

Price Target Revisions

1 Month
-36.11%
3 Months
-36.11%

Price Target Summary

9 Wall Street analysts provided a forecast for the next 12 months for SRNE. The average price target is 7.82 USD. This implies a price increase of 2444.75% is expected in the next year compared to the current price of 0.3073.
The average price target has been revised downward by 36.11% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

SRNE Current Analyst RatingSRNE Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

SRNE Historical Analyst RatingsSRNE Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
82.22%
SRNE was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about SRNE.
In the previous month the buy percentage consensus was at a similar level.
SRNE was analyzed by 9 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2022-11-02Cantor FitzgeraldInitiate Overweight
2021-08-09HC Wainwright & Co.Maintains Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A
Period
Q4 / 2022
EPS Estimate
-$0.23
Revenue Estimate
16.905M
Revenue Q2Q
29.28%
EPS Q2Q
50.09%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
21.31%
EPS (1 Month)
0.00%
EPS (3 Months)
6.12%

Next Earnings Summary

The next earnings revenue estimate has been revised upward by 21.31% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2022 - 2024

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2019 2020 2021 2022 2023 2024
Revenue
YoY % growth
SRNE revenue by date.SRNE revenue by date.
31.4M
48.11%		40M
27.39%		52.904M
32.26%		58.222M
10.05%		53.272M
-8.50%		207.44M
289.40%
EBITDA
YoY % growth
SRNE ebitda by date.SRNE ebitda by date.
-248.41M
-75.74%		-233.59M
5.97%		-388.989M
-66.53%		N/AN/AN/A
EBIT
YoY % growth
SRNE ebit by date.SRNE ebit by date.
-259.4M
-72.47%		-244.6M
5.71%		-401.451M
-64.13%		-404.9M
-0.86%		-394.552M
2.56%		-238.206M
39.63%
Operating Margin
SRNE operating margin by date.SRNE operating margin by date.
-826.11%-611.50%-758.83%-695.44%-740.64%-114.83%
EPS
YoY % growth
SRNE eps by date.SRNE eps by date.
-2.25
-52.03%		-1.19
47.11%		-1.43
-20.17%		-1.20
15.83%		-0.90
25.00%		-0.53
41.81%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 22
EPS
Q2Q % growth		-0.23
50.09%
Revenue
Q2Q % growth		16.905M
29.28%
EBITDA
Q2Q % growth		N/A
EBIT
Q2Q % growth		-97.046M
15.32%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

SRNE Yearly Revenue VS EstimatesSRNE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
SRNE Yearly EPS VS EstimatesSRNE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1 -1 -2

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
17.75%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
54.67%
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

SORRENTO THERAPEUTICS INC / SRNE Forecast FAQ

What is the average price target for SORRENTO THERAPEUTICS INC (SRNE) stock?

9 analysts have analysed SRNE and the average price target is 7.82 USD. This implies a price increase of 2444.75% is expected in the next year compared to the current price of 0.3073.

Can you provide the consensus estimates for SORRENTO THERAPEUTICS INC next earnings?

The consensus EPS estimate for the next earnings of SORRENTO THERAPEUTICS INC (SRNE) is -0.23 USD and the consensus revenue estimate is 16.91M USD.

What is the number of analysts for SRNE stock?

The number of analysts covering SORRENTO THERAPEUTICS INC (SRNE) is 9.